The HSJ ICS Medicines Forum was sponsored by the following industry partners: BIAL, Daichii Sankyo, Optum, Sandoz, Spirit Health, Accord, ALTURiX and Novartis. Four partners had responsibility for their individual workshop sessions. They had no editorial involvement in the broader HSJ Medicines Forum agenda, which HSJ retained full control and responsibility for.
The new integrated care landscape ushers in changes for most healthcare professionals, but the impact for pharmacy is particularly marked. ISC/ICB Chief Pharmacists are now looking after medicines across primary and secondary care, and working with community pharmacy and in care settings.
Pharmacy teams are also taking on more specialised commissioning responsibilities, trying to tackling waste/recycling/sustainability, having to handle shortages and supply chain problems, leading on digitisation and e-prescribing, and addressing prescribing and population health management in the context of reducing health inequalities.
Join us as we showcase how integrated care systems might improve the use and management of medicines to advance the triple aims of improving health outcomes and the quality of care, while also ensuring value and savings.